Ameriprise’s Xponential Fitness XPOF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,463,682
Closed -$11.4M 4229
2025
Q3
$11.4M Buy
1,463,682
+109,432
+8% +$998K ﹤0.01% 1823
2025
Q2
$10.1M Sell
1,354,250
-383,736
-22% -$3.18M ﹤0.01% 1812
2025
Q1
$14.5M Buy
1,737,986
+26,394
+2% +$368K ﹤0.01% 1526
2024
Q4
$23M Buy
1,711,592
+92,477
+6% +$1.27M 0.01% 1241
2024
Q3
$20.1M Buy
1,619,115
+141,067
+10% +$2.07M 0.01% 1330
2024
Q2
$23.1M Buy
1,478,048
+200,546
+16% +$2.47M 0.01% 1192
2024
Q1
$21.1M Buy
1,277,502
+241,440
+23% +$2.97M 0.01% 1263
2023
Q4
$13.4M Buy
1,036,062
+123,386
+14% +$1.67M ﹤0.01% 1548
2023
Q3
$14.1M Sell
912,676
-1,001,244
-52% -$19.6M ﹤0.01% 1449
2023
Q2
$33M Sell
1,913,920
-324,219
-14% -$9.18M 0.01% 966
2023
Q1
$68M Buy
2,238,139
+1,139,511
+104% +$30.2M 0.02% 630
2022
Q4
$25.2M Sell
1,098,628
-58,936
-5% -$1.22M 0.01% 1082
2022
Q3
$21.1M Sell
1,157,564
-19,357
-2% -$326K 0.01% 1148
2022
Q2
$14.7M Buy
1,176,921
+308,780
+36% +$5.56M 0.01% 1441
2022
Q1
$20.3M Buy
868,141
+132,730
+18% +$2.59M 0.01% 1341
2021
Q4
$15M Buy
+735,411
New +$13.7M ﹤0.01% 1632

Other funds holding XPOF

Ameriprise's XPOF Position: Q4 2025 in Review

Ameriprise sold out of Xponential Fitness (XPOF) in Q4 2025, closing a stake of 1,463,682 shares — an estimated $11.4M sold.

Ameriprise first reported a position in XPOF in Q4 2021 and held it in 16 quarters. The position peaked at $68M in Q1 2023. 115 funds tracked by Wall St. Rank hold XPOF as of Q4 2025.

  • Ameriprise reported no remaining Xponential Fitness position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 1,463,682 Xponential Fitness shares in Q4 2025, an estimated $11.4M.
  • Ameriprise first reported a position in Xponential Fitness in Q4 2021 and held it in 16 quarters.
  • Ameriprise's Xponential Fitness position peaked at $68M in Q1 2023.
  • 115 funds tracked by Wall St. Rank held Xponential Fitness as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.